These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9056158)

  • 41. Contrast media effects on hemostatic and thrombotic parameters. Possible consequences for practical techniques and prophylactic measures.
    Stormorken H; Sakariassen KS
    Acta Radiol Suppl; 1995; 399():173-81. PubMed ID: 8610511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
    Davidson CJ; Laskey WK; Hermiller JB; Harrison JK; Matthai W; Vlietstra RE; Brinker JA; Kereiakes DJ; Muhlestein JB; Lansky A; Popma JJ; Buchbinder M; Hirshfeld JW
    Circulation; 2000 May; 101(18):2172-7. PubMed ID: 10801758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology.
    Chronos NA; Goodall AH; Wilson DJ; Sigwart U; Buller NP
    Circulation; 1993 Nov; 88(5 Pt 1):2035-44. PubMed ID: 8222096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood clot formation in angiographic syringes containing nonionic contrast media.
    Robertson HJ
    Radiology; 1987 Mar; 162(3):621-2. PubMed ID: 3809474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfaces.
    Riemann CD; Massey CV; McCarron DL; Borkowski P; Johnson PC; Ziskind AA
    Am Heart J; 1993 Jan; 125(1):71-8. PubMed ID: 8417545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of contrast media on blood coagulation system].
    Sviridov NK
    Vestn Khir Im I I Grek; 1975 Mar; 114(3):133-4. PubMed ID: 1119023
    [No Abstract]   [Full Text] [Related]  

  • 47. In vivo effects of nonionic and ionic contrast media on beta-thromboglobulin and fibrinopeptide levels.
    Arora R; Khandelwal M; Gopal A
    J Am Coll Cardiol; 1991 Jun; 17(7):1533-6. PubMed ID: 1827810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical evidence for a relative lack of inhibition of thrombin formation by nonionic contrast media.
    Mamon JF; Hoppensteadt D; Fareed J; Moncada R
    Radiology; 1991 May; 179(2):399-402. PubMed ID: 2014281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differing mechanisms of clotting inhibition by ionic and nonionic contrast agents.
    Ing JJ; Smith DC; Bull BS
    Radiology; 1989 Aug; 172(2):345-8. PubMed ID: 2748812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin supplementation of nonionic contrast agents.
    Massee DR; Smith DC; Westengard JC; Bull BS
    J Vasc Interv Radiol; 1991 May; 2(2):209-13. PubMed ID: 1799759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of contrast media under systemic heparinization on blood coagulation and fibrinolytic system during angiocardiography--comparison of ionic and nonionic contrast media].
    Himi K; Takemoto A; Himi S; Kamata R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Aug; 52(8):1139-47. PubMed ID: 1408685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiographic contrast media and the coagulation and complement systems.
    Hoffmeister HM; Heller W
    Invest Radiol; 1996 Sep; 31(9):591-5. PubMed ID: 8877497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT study.
    Bellemain-Appaix A; Beygui F; Lesty C; Gupta S; Silvain J; Le Feuvre C; Cayla G; Allali Y; Montalescot G; Collet JP
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):823-33. PubMed ID: 21618678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative cytotoxicity of low- and high-osmolar contrast media to human fibroblasts and rat mesangial cells in culture.
    Potier M; Lagroye I; Lakhdar B; Cambar J; Idee JM
    Invest Radiol; 1997 Oct; 32(10):621-6. PubMed ID: 9342122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of radiographic contrast media on pulmonary vascular resistance of normoxic and chronically hypoxic pulmonary hypertensive rats.
    Emery CJ; Fang L; Laude EA; Morcos SK
    Br J Radiol; 2001 Dec; 74(888):1109-17. PubMed ID: 11777768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allergic-type adverse reactions to low osmolality contrast media in patients with a history of allergy or asthma.
    Simon MR
    Invest Radiol; 1995 May; 30(5):285-90. PubMed ID: 7558732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrast agents for cardiac catheterization: conceptions and misconceptions.
    Brogan WC; Hillis LD; Lange RA
    Am Heart J; 1991 Oct; 122(4 Pt 1):1129-35. PubMed ID: 1927863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro comparison of the effects of contrast media on coagulation and platelet activation.
    Corot C; Chronos N; Sabattier V
    Blood Coagul Fibrinolysis; 1996 Sep; 7(6):602-8. PubMed ID: 8899149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.
    Sutton AG; Finn P; Grech ED; Hall JA; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2001 Apr; 141(4):677-83. PubMed ID: 11275937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selection of radiocontrast media in cardiac catheterization: comparative physiology and clinical effects of nonionic monomeric and ionic dimeric formulations.
    Kern MJ
    Am Heart J; 1991 Jul; 122(1 Pt 1):195-201. PubMed ID: 2063737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.